Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study

References

• GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Weinberg HN. Fundamentals of Family Medicine. 3 ed. New York, NY: Springer; 2003. doi:10.1007/978-0-387-21745-1
   Google Scholar
• Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
   PubMed Web of Science ®Google Scholar
• Sekine Y, Yanagibori R, Suzuki K, et al. Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening. Int J Chron Obstruct Pulmon Dis. 2014;9:647–656. doi:10.2147/COPD.S62053
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535
   PubMed Web of Science ®Google Scholar
• Fu SN, Yu WC, Wong CK, Lam MC. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting. Int J Chron Obstruct Pulmon Dis. 2016;11:2391–2399. doi:10.2147/COPD.S106306
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology. 2004;9(4):458–465. doi:10.1111/j.1440-1843.2004.00637.x
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: https://ginasthma.org/gina-reports/. Accessed September 7, 2021.
   Google Scholar
• Labonte LE, Tan WC, Li PZ, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD study. Am J Respir Crit Care Med. 2016;194(3):285–298. doi:10.1164/rccm.201509-1795OC
   PubMed Web of Science ®Google Scholar
• Gershon AS, Thiruchelvam D, Chapman KR, et al. Health services burden of undiagnosed and overdiagnosed COPD. Chest. 2018;153(6):1336–1346. doi:10.1016/j.chest.2018.01.038
   PubMed Web of Science ®Google Scholar
• Cooke CE, Sidel M, Belletti DA, Fuhlbrigge AL. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD. 2012;9(1):73–80. doi:10.3109/15412555.2011.631957
   PubMedGoogle Scholar
• Zielinski J, Bednarek M, Gorecka D, et al. Increasing COPD awareness. Eur Respir J. 2006;27(4):833–852. doi:10.1183/09031936.06.00025905
   PubMed Web of Science ®Google Scholar
• Price D, Crockett A, Arne M, et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J. 2009;18(3):216–223. doi:10.4104/pcrj.2009.00055
   PubMedGoogle Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-3
   PubMed Web of Science ®Google Scholar
• Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J. 2006;15(1):20–34. doi:10.1016/j.pcrj.2005.10.004
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD; 2021. Available from: https://goldcopd.org/gold-reports/. Accessed September 7, 2021.
   Google Scholar
• Wijnant SRA, De Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam study. Eur Respir J. 2020;55(1):1901217. doi:10.1183/13993003.01217-2019
   PubMed Web of Science ®Google Scholar
• Adibi A, Sadatsafavi M. Looking at the COPD spectrum through “PRISm”. Eur Respir J. 2020;55. doi:10.1183/13993003.02217-2019.
   PubMed Web of Science ®Google Scholar
• Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15:89. doi:10.1186/s12931-014-0089-y
   PubMed Web of Science ®Google Scholar
• Wan ES, Fortis S, Regan EA, et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med. 2018;198(11):1397–1405. doi:10.1164/rccm.201804-0663OC
   PubMed Web of Science ®Google Scholar
• Lowe KE, Regan EA, Anzueto A, et al. COPDGene(®) 2019: redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2019;6(5):384–399.
   PubMed Web of Science ®Google Scholar
• Tamaki K, Sakihara E, Miyata H, et al. Utility of self-administered questionnaires for identifying individuals at risk for COPD in Japan: the OCEAN (Okinawa COPD casE finding AssessmeNt) study. TBC. 2020;16:1771.
   Google Scholar
• Martinez FJ, Mannino D, Leidy NK, et al. A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(6):748–756. doi:10.1164/rccm.201603-0622OC
   PubMed Web of Science ®Google Scholar
• Reddel HK, Gerhardsson de Verdier M, Agustí A, et al. Prospective observational study in patients with obstructive lung disease: NOVELTY design. ERJ Open Res. 2019;5(1):00036–2018. doi:10.1183/23120541.00036-2018
   PubMedGoogle Scholar
• Samukawa T, Matsumoto K, Tsukuya G, et al. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis. 2017;12:1469–1481. doi:10.2147/COPD.S130453
   PubMed Web of Science ®Google Scholar
• Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014;44(4):873–884. doi:10.1183/09031936.00025214
   PubMed Web of Science ®Google Scholar
• Mirsadraee M, Boskabady MH, Attaran D. Diagnosis of chronic obstructive pulmonary disease earlier than current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter (maximal-mid expiratory flow/forced vital capacity). Chron Respir Dis. 2013;10(4):191–196. doi:10.1177/1479972313507461
   PubMed Web of Science ®Google Scholar
• Stockley JA, Ismail AM, Hughes SM, Edgar R, Stockley RA, Sapey E. Maximal mid-expiratory flow detects early lung disease in α(1)-antitrypsin deficiency. Eur Respir J. 2017;49(3):1602055. doi:10.1183/13993003.02055-2016
   PubMed Web of Science ®Google Scholar
• Park HJ, Byun MK, Rhee CK, Kim K, Kim HJ, Yoo KH. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study. Respir Res. 2018;19(1):185. doi:10.1186/s12931-018-0896-7
   PubMedGoogle Scholar
• Sood A, Petersen H, Qualls C, et al. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. Respir Res. 2016;17(1):147. doi:10.1186/s12931-016-0468-7
   PubMed Web of Science ®Google Scholar
• McGeachie MJ, Yates KP, Zhou X, et al. Patterns of growth and decline in lung function in persistent childhood asthma. N Engl J Med. 2016;374(19):1842–1852. doi:10.1056/NEJMoa1513737
   PubMed Web of Science ®Google Scholar
• Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax. 2014;69(9):805–810. doi:10.1136/thoraxjnl-2013-204815
   PubMed Web of Science ®Google Scholar
• Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935–939. doi:10.1136/thx.2006.062802
   PubMed Web of Science ®Google Scholar
• Parekh TM, Bhatia S, Cherrington A, et al. Factors influencing decline in quality of life in smokers without airflow obstruction: the COPDGene study. Respir Med. 2020;161:105820. doi:10.1016/j.rmed.2019.105820
   PubMed Web of Science ®Google Scholar
• Strand M, Austin E, Moll M, et al. A risk prediction model for mortality among smokers in the COPDGene® study. Chronic Obstr Pulm Dis. 2020;7(4):346–361.
   PubMed Web of Science ®Google Scholar